Uncategorized

Eyes on the yield in emerging markets corporates

| November 20, 2020

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

With many investors looking for yield somewhere in the constellation of debt markets, the yield in emerging markets corporate debt should draw attention in 2021. Emerging markets US dollar corporates offer much wider spreads to both US investment grade and high yield. A handful of opportunities are already in the market. And the opportunities come against a background of steady if uneven economic recovery from pandemic.

Incremental yield to US credit

EM corporate debt still offers incremental yield and spread to US credit. The JPM EM Corporate Bond Index—CEMBI Broad, including both corporate investment grade and high yield issuers—has a spread-to-worst of 300 bp over the US Treasury curve and a yield-to-worse of 3.77%. The JPMorgan EMBI Global index, including sovereign issuers only, has a STW of 377 bp as of mid-November and a YTW of 4.79%. In addition, CEMBIG at 300 bp, is still far away from all-time lows of 157 bp.

Incremental yield to US investment grade

EM corporate IG offers an attractive pick-up to US IG. The JPMorgan CEMBI Broad IG index (Baa2/BBB-) at a STW of 185 bp and YTW of 2.7% offers a pick-up of 76 bp to the Barclays US Corporate Aggregate index, which has a YTW of 1.9% and OAS of 109 bp. Within EM, from a relative value perspective, CEMBI Latin America IG has the biggest pick-up to US HG at 81 bp, followed by EM Europe 64 bp, while Asia IG at 21 bp looks less attractive relative to US compared to Asia HY.

Incremental yield to US high yield

EM corporate high yield also offers incremental spread, though investors need to be selective across regions and credits. EM high yield should perform well based on EM and developed market expected economic rebound in 2021 driven by consumer demand in BRICs and the implementation of a Covid-19 vaccine. The regions that offer more yield are Asia followed by Latin America. In Latin America, various sectors could still outperform including financials, transportation, infrastructure and consumer. Oil and gas state-owned credits look more challenged as risk mixes oil volatility, levered balance sheets, and weakness of sovereigns that own the national oil companies.

Opportunistic trade ideas in Latin America corporates

AESGEN 6.35% 2079 (callable in 2025) YTC 5.25% Jr Sub (Ba2/BB). AES Gener (Baa3/BBB-) is AES Corp’s subsidiary in South America with core operations in Chile (A+/A-) and Colombia. AES Gener has a net leverage of 3.4x, a solid cash position of $1 billion and a soft amortization schedule. Company it is growing its green portfolio in Chile and divesting from coal assets. Existing bond pays a premium over most other utilities in the same ZIP code (200 bp to 300 bp) due to subordination, lower rating and expectations around reset date. A YTC of 5.25% it is a reasonable proposal for a defensive 4.5-year paper with a committed and global energy shareholder (AES) with reasonable expectations to be called on 04/2025 when rate resets to UST5 year. + 4.91%.

One way to play a Mexican recovery in 2021 is through Banorte Tier II perpetuals, offering 4- to 10-year tenors if called at reset dates (currently trading to call) with YTC from 5.5% to 6.6%. Banorte is an IG issuer (Baa1/BBB-) while Jr. subordinated paper is BB-/Ba2. The bank has ample liquidity, is well funded and capitalized, as such, there are reasonable expectations for bonds to be called at reset/call date, as bank wants to keep the doors open for further issuance. Banorte is the second largest bank in Mexico by assets ($81 billion). As the US economy rebounds the Mexican economy should follow (expected GDP Growth Mexico in 2021 +3.5% based on Bloomberg), benefiting the consumer and banking sector which are deeply ingrained. Banorte has solid metrics as of 3Q20 with a market cap of $15.5 billion, revenues of $7 billion and net income of $1.6 billion. It has a solid capitalization ratio of 21.1% (Tier 2 – 13.7%), ROEs of 16.9%, declining NPLs of 0.8%, total loans of $38 billion, NIMs of 5.8% and has a provision of 265% of NPLs.

Brazil’s economic recovery story is already reflected on much better third quarter 2020 earnings across sectors, with GDP 2021E +3.5% (Bloomberg average). As the economy grows in 2021, banks and consumer companies like Cosan (CZZ 5.5% 2029), Rumo and Braskem will benefit. In addition, commodity players levered to Asia’s growth like Vale, CSN, Suzano will benefit from a commodities pricing boom while accessing to cheap financing in Brazil and overseas, posing potential spread compression as more funds enter the asset class in the search of yield.

Wide spreads against a background of rebounding growth

The opportunities in emerging markets corporate debt come as economic recovery in the second half of 2020 has been steady if uneven, varying across country and region. Asia has led, driven by China. EM recovery has been driven mainly by a handful of factors:

  • A pick-up in consumer activity in the largest economies during the second half of 2020
  • China’s early response to pandemic and economic it’s rebound in 2020 and 2021, with the Bloomberg average 2021 GDP forecast for China at 8.1%
  • A pick-up in commodity prices after the second quarter of 2020, driven by strong Chinese demand for iron ore, copper, natural gas and agriculture
  • Expansive fiscal policy by local governments and accommodative monetary policy by global central banks, and
  • A US trade deficit and US dollar weakness

The recovery has been reflected in a healthy rebound in corporate earnings across EM during the third quarter of 2020 in tandem with a rally in EM asset prices. Since the March lows, EM benchmarks have performed as follows: MSCI EM +58%, EMBI spreads tightened from 650 bp to 350 bp, equity indexes Bovespa +68%, Mexbol +27%, Shenzhen +40%.

EM corporates has become a more mature asset class with a total USD size of $2.5 trillion. The EM primary issuance market has been very active with total corporate issuance of $451 billion YTD of which Asia is 64%, CEEMEA 21% and Latin America 15%, according to Bond Radar. . In 2021, EM corporate issuance is estimated to surpass that number. Bond refinancing, redemptions and net new issuance should make 2021 a very active year in EM credit.

After a challenging second quarter of 2020, EM debt outflows reverted. However, despite EM corporate debt becoming a more mature asset class it is still a volatile one, driven by yearly and sometimes quarterly changes in fund inflows and outflows dynamics in both debt and equities, affecting the different EM debt sub-asset classes: hard currency, local currency and blended. Still, EM is expected to continue to attract assets.

Sovereign risk matters creating dislocations between sovereigns and corporates, strong companies in smaller and weaker or stressed jurisdictions trade at a premium for example in Central America. This dynamic creates asymmetric risk/reward opportunities in less known or traded corporates with strong balance sheets and a dominant position in their markets (i.e.: utilities, banks) offering high single digit or low double digits yields, usually above the embattled sovereigns.

EM corporates still offer an attractive entry point, with Asia high yield and Latin America high yield and investment grade as the most attractive regions and sub-sectors to play from a relative value basis. Credit and country differentiation will be key in portfolio construction while the primary market will be very active in 2021.

admin
jkillian@apsec.com
john.killian@santander.us 1 (646) 776-7714

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

Important disclaimers for clients in the EU and UK

This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).

The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.

This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.

This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.

This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.

The Library

Search Articles